Skip to main content
. 2021 Feb 5;16(6):1593–1603. doi: 10.1007/s11739-021-02655-6
Appendix. List of corticosteroids
Observed frequency Given dose
Included steroids—as any given medications were recorded in EHR n (%) (Low, high)
DEXAMETHASONE 2 MG PO TABS 1/615 (0.16%) 10 mg
DEXAMETHASONE 4 MG PO TABS 1/615 (0.16%) 16 mg
DEXAMETHASONE SOD PHOS 10 MG/ML IJ SUPERORDERABLE OHS 11/615 (1.79%) (0.8 mg, 10 mg)
DEXAMETHASONE SOD PHOS 4 MG/ML IJ SUPERORDERABLE OHS 2/615 (0.33%) (4 mg, 10 mg)
DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML INJ SOLN 3/615 (0.49%) 10 mg
DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJ SOLN 11/615 (1.79%) (1 mg, 8 mg)
HYDROCORTISONE NA SUCCINATE PF 100 MG INJ SOLR 57/615 (9.27%) (12.5 mg, 100 mg)
HYDROCORTISONE SOD SUCC 100 MG IJ SOLR SUPERORDERABLE OHS 16/615 (2.60%) (25 mg, 100 mg)
METHYLPREDNISOLONE IVPB 126—999 MG 1/615 (0.16%) 500 mg
METHYLPREDNISOLONE SODIUM SUCC 125 MG INJ SOLR 187/615 (30.41%) (1 mg, 250 mg)
METHYLPREDNISOLONE SODIUM SUCC 40 MG INJ SOLR 431/615 (70.08%) (20 mg, 80 mg)
METHYLPREDNISOLONE TO 500 MG IVPB OHS 2/615 (0.33%) (40 mg, 500 mg)
PREDNISONE 20 MG PO TABS 76/615 (12.36%) (10 mg, 80 mg)
PREDNISONE 50 MG PO TABS 9/615 (1.46%) 50 mg
HYDROCORTISONE (SOLU-CORTEF) 100 MG INJECTION CABINET OVERRIDE 4/615 (0.65%) (45 mg, 100 mg)
METHYLPREDNISOLONE SODIUM SUCCINATE (SOLU-MEDROL) 125MG / 2ML INJECTION CABINET OVERRIDE 1/615 (0.16%) 125 mg
Note: Each of 615 patients who were counted as recipients of corticosteroid treatment was given one or more than one included steroids during hospitalization
Excluded steroids—as any given medications were recorded in EHR
PREDNISONE 10 MG PO TABS
PREDNISONE 5 MG PO TABS
BUDESONIDE 3 MG PO CPEP
PREDNISOLONE 5 MG PO TABS
HYDROCORTISONE 10 MG PO TABS
PREDNISONE 1 MG PO TABS
METHYLPREDNISOLONE 4 MG PO TABS
FLUTICASONE FUROATE-VILANTEROL 100–25 MCG/INH INHAL AEPB
FLUTICASONE FUROATE-VILANTEROL 200–25 MCG/INH INHAL AEPB
BUDESONIDE 0.5 MG/2ML INHAL SUSP
FLUTICASONE PROPIONATE HFA 44 MCG/ACT INHAL AERO